Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lisata Therapeutics (LSTA)
NASDAQ:LSTA
RESEARCH TOOLSreports
Lisata Therapeutics (LSTA) Stock Price & Analysis
1,010 Followers
LSTA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.95 - $4.53
Previous Close$2.58
Volume16.27K
Average Volume (3M)20.37K
Market Cap
$20.01M
Enterprise Value-$34.64M
Total Cash (Recent Filing)$54.39M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.0
Beta1.12
Next Earnings
Mar 28, 2024EPS Estimate
-$0.86Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.68
Shares Outstanding8,139,449
10 Day Avg. Volume26,704
30 Day Avg. Volume20,374
Standard Deviation0.18
R-Squared0.12
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.38
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda1.39
Forecast
1Y Price Target
$15.00Price Target Upside474.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Lisata Therapeutics News
Pre-EarningsLSTA Earnings this Week: How Will it Perform?
LSTA FAQ
What was Lisata Therapeutics’s price range in the past 12 months?
Lisata Therapeutics lowest stock price was $1.95 and its highest was $4.53 in the past 12 months.
What is Lisata Therapeutics’s market cap?
Currently, no data Available
When is Lisata Therapeutics’s upcoming earnings report date?
Lisata Therapeutics’s upcoming earnings report date is Mar 28, 2024 which is in 110 days.
How were Lisata Therapeutics’s earnings last quarter?
Lisata Therapeutics released its earnings results on Nov 02, 2023. The company reported -$0.65 earnings per share for the quarter, beating the consensus estimate of -$0.93 by $0.28.
Is Lisata Therapeutics overvalued?
According to Wall Street analysts Lisata Therapeutics’s price is currently Undervalued.
Does Lisata Therapeutics pay dividends?
Lisata Therapeutics does not currently pay dividends.
What is Lisata Therapeutics’s EPS estimate?
Lisata Therapeutics’s EPS estimate is -$0.86.
How many shares outstanding does Lisata Therapeutics have?
Lisata Therapeutics has 8,139,449 shares outstanding.
What happened to Lisata Therapeutics’s price movement after its last earnings report?
Lisata Therapeutics reported an EPS of -$0.65 in its last earnings report, beating expectations of -$0.93. Following the earnings report the stock price went up 8.257%.
Which hedge fund is a major shareholder of Lisata Therapeutics?
Among the largest hedge funds holding Lisata Therapeutics’s share is RA Capital Management. It holds Lisata Therapeutics’s shares valued at N/A.
---
Lisata Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (474.71% Upside)
$15.00 (474.71% Upside)
Hedge Fund Trend
Decreased
By 50.2K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.85%
12-Months-Change
Fundamentals
Return on Equity
-34.35%
Trailing 12-Months
Asset Growth
-26.03%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Lisata Therapeutics
Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in developing products in cardiovascular and autoimmune disease that have the potential to restore the health of people with chronic illnesses. Its product pipeline includes CLBS12, CLBS14, and CLBS03. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.
---
Top 5 ETFs holding LSTA
Vanguard Total Stock Market ETF
$254.42K
iShares Core S&P Total U.S. Stock Market ETF
$1.43K
Up to five ETFs with an Outperform Smart Score that hold LSTA. The ETFs are listed according to market value of LSTA within the ETF
---